A
Allogene Therapeutics, Inc.
ALLO · NASDAQ · Healthcare · 708M
Price · close
$2.09
-0.48% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
1.6×
Enterprise value / EBITDAEV/EBITDA
-2.8×
Free cash flow yieldFCF yield
-32.5%
Return on equityROE
-65.3%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
-0.2×
Interest coverage
-192.5×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.